title: [Idiopathic multiple cerebral hemorrhage: are platelet anti-aggregation agents a risk factor?].
authors.forename: A
authors.initials: A
authors.lastname: Arjona
authors.forename: M T
authors.initials: MT
authors.lastname: Bartolomé
authors.forename: M
authors.initials: M
authors.lastname: Mata
authors.forename: F
authors.initials: F
authors.lastname: Corral
authors.forename: M R
authors.initials: MR
authors.lastname: Blasco
authors.forename: C
authors.initials: C
authors.lastname: Jiménez
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D002543:Cerebral Hemorrhage / Q000139:chemically induced* / Q000175:diagnosis; D005260:Female; D006801:Humans; D002546:Ischemic Attack, Transient / Q000175:diagnosis / Q000188:drug therapy; D008297:Male; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D012307:Risk Factors; D014057:Tomography, X-Ray Computed
chemical_list: D010975:Platelet Aggregation Inhibitors
vernacular_title: Hemorragia cerebral múltiple idiopática: son los antiagregantes plaquetarios un factor de riesgo?